 | FibroGen Inc (NASDAQ:FGEN) Short Interest Up 5.8% in October
www.americanbankingnews.com - November 16 at 11:14 PM |
| FibroGen Inc (NASDAQ:FGEN) Expected to Announce Quarterly Sales of $50.68 Million
www.americanbankingnews.com - November 16 at 2:52 AM |
| Insider Selling: FibroGen Inc (NASDAQ:FGEN) SVP Sells 5,625 Shares of Stock
www.americanbankingnews.com - November 15 at 8:44 PM |
| Brokers Issue Forecasts for FibroGen Inc's FY2019 Earnings (NASDAQ:FGEN)
www.americanbankingnews.com - November 15 at 11:46 AM |
| FY2019 EPS Estimates for FibroGen Inc (NASDAQ:FGEN) Lifted by Svb Leerink
www.americanbankingnews.com - November 15 at 11:46 AM |
 | FIBROGEN ALERT: Bragar Eagel & Squire, P.C. is Investigating FibroGen, Inc. on Behalf of Stockholders and Encourages Investors to Contact the Firm
www.benzinga.com - November 15 at 3:52 AM |
 | FIBROGEN ALERT: Bragar Eagel & Squire, P.C. is Investigating FibroGen, Inc. on Behalf of Stockholders and Encourages Investors to Contact the Firm - Business Wire
www.businesswire.com - November 14 at 10:51 PM |
 | Edited Transcript of FGEN earnings conference call or presentation 11-Nov-19 10:00pm GMT - Yahoo Finance
finance.yahoo.com - November 14 at 5:49 PM |
| Edited Transcript of FGEN earnings conference call or presentation 11-Nov-19 10:00pm GMT
finance.yahoo.com - November 14 at 5:49 PM |
| Brokerages Anticipate FibroGen Inc (NASDAQ:FGEN) to Post -$0.39 EPS
www.americanbankingnews.com - November 14 at 3:40 PM |
| FibroGen Inc (NASDAQ:FGEN) Expected to Post Q1 2021 Earnings of $0.46 Per Share
www.americanbankingnews.com - November 14 at 5:07 AM |
| FibroGen Inc Expected to Earn Q4 2020 Earnings of $0.95 Per Share (NASDAQ:FGEN)
www.americanbankingnews.com - November 14 at 5:02 AM |
 | HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages FibroGen (FGEN) Investors to Contact Its Attorneys, Firm Investigating Possible Securities Fraud - GlobeNewswire
www.globenewswire.com - November 14 at 12:47 AM |
| INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation on Behalf of FibroGen, Inc. Investors - Business Wire
www.businesswire.com - November 14 at 12:47 AM |
| Glancy Prongay & Murray LLP Announces Investigation on Behalf of FibroGen, Inc. Investors - Business Wire
www.businesswire.com - November 14 at 12:47 AM |
| HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages FibroGen (FGEN) Investors to Contact Its Attorneys, Firm Investigating Possible Securities Fraud
finance.yahoo.com - November 14 at 12:47 AM |
| Svb Leerink Weighs in on FibroGen Inc's Q3 2020 Earnings (NASDAQ:FGEN)
www.americanbankingnews.com - November 14 at 12:17 AM |
| INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation on Behalf of FibroGen, Inc. Investors
finance.yahoo.com - November 13 at 7:46 PM |
| Glancy Prongay & Murray LLP Announces Investigation on Behalf of FibroGen, Inc. Investors
finance.yahoo.com - November 13 at 7:46 PM |
| FibroGen (FGEN) Soars: Stock Adds 9.6% in Session - Yahoo Finance
finance.yahoo.com - November 13 at 9:44 AM |
 | FibroGen, Inc. (FGEN) CEO James Schoeneck on Q3 2019 Results - Earnings Call Transcript - Seeking Alpha
seekingalpha.com - November 13 at 9:44 AM |
 | Muddywaters Research links to a cautious report on FibroGen (FGEN) - StreetInsider.com
www.streetinsider.com - November 12 at 10:27 PM |
| FibroGen adds to selloff, down 5% on bearish Muddy Waters report - Seeking Alpha
seekingalpha.com - November 12 at 5:27 PM |
| FibroGen Overcomes Safety Hurdle; Clear Path Towards FDA Approval For CKD Patients - Seeking Alpha
seekingalpha.com - November 12 at 12:26 PM |
| Traders Purchase Large Volume of Put Options on FibroGen (NASDAQ:FGEN)
www.americanbankingnews.com - November 12 at 11:53 AM |
| FibroGen Inc Forecasted to Post FY2020 Earnings of $1.43 Per Share (NASDAQ:FGEN)
www.americanbankingnews.com - November 12 at 11:13 AM |
| FibroGen (NASDAQ:FGEN) Posts Earnings Results, Beats Estimates By $0.02 EPS
www.americanbankingnews.com - November 12 at 8:33 AM |
 | FibroGen Inc (FGEN) Q3 2019 Earnings Call Transcript - The Motley Fool
www.fool.com - November 12 at 7:21 AM |
| FibroGen (FGEN) Reports Q3 Loss, Tops Revenue Estimates - Yahoo Finance
finance.yahoo.com - November 12 at 12:49 AM |
| FibroGen (FGEN) PT Raised to $72 at Mizuho Securities on Strong Ph3 MACE Data - StreetInsider.com
www.streetinsider.com - November 11 at 7:49 PM |
 | FibroGen (FGEN) Reports Q3 Loss, Tops Revenue Estimates - Nasdaq
www.nasdaq.com - November 11 at 7:49 PM |
| FibroGen Reports Third Quarter 2019 Financial Results Nasdaq:FGEN - GlobeNewswire
www.globenewswire.com - November 11 at 7:49 PM |
| FibroGen (FGEN) Reports Q3 Loss, Tops Revenue Estimates
finance.yahoo.com - November 11 at 7:49 PM |
| Here’s Why FibroGen’s Stock Popped Friday - Motley Fool
www.fool.com - November 11 at 2:48 PM |
| FibroGen (FGEN) Soars: Stock Adds 9.6% in Session - Nasdaq
www.nasdaq.com - November 11 at 2:48 PM |
| FibroGen (NASDAQ:FGEN) Given "Positive" Rating at Mizuho
www.americanbankingnews.com - November 11 at 9:12 AM |
| FibroGen Inc (NASDAQ:FGEN) Director Kalevi Kurkijarvi Sells 6,000 Shares
www.americanbankingnews.com - November 8 at 7:31 PM |
| FibroGen shares halted pending news - Seeking Alpha
seekingalpha.com - November 8 at 6:01 PM |
| FibroGen up 16% as safety concerns with roxadustat ebb - Seeking Alpha
seekingalpha.com - November 8 at 6:01 PM |
| FibroGen down 6% despite positive roxadustat date in late-stage CKD study - Seeking Alpha
seekingalpha.com - November 8 at 1:00 PM |
| FibroGen (FGEN) Highlights Results from Ph. 3 HIMALAYAS Trial Evaluating Roxadustat for Treatment of Anemia in Incident Dialysis Patients - StreetInsider.com
www.streetinsider.com - November 8 at 7:59 AM |
| FibroGen Presents Phase 3 Efficacy and Safety Results for Roxadustat Versus Epoetin Alfa as Treatment of Anemia in Incident Dialysis Patients with Chronic Kidney Disease - GlobeNewswire
www.globenewswire.com - November 7 at 6:59 PM |
| FibroGen Presents Phase 3 Efficacy and Safety Results for Roxadustat Versus Epoetin Alfa as Treatment of Anemia in Incident Dialysis Patients with Chronic Kidney Disease
finance.yahoo.com - November 7 at 6:59 PM |
| SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of FibroGen, Inc. - FGEN - Yahoo Finance
finance.yahoo.com - November 6 at 4:25 PM |
| Bronstein, Gewirtz & Grossman, LLC Announces Investigation of FibroGen, Inc. (FGEN) - Yahoo Finance
finance.yahoo.com - November 6 at 11:25 AM |
| Karyopharm (KPTI) Catches Eye: Stock Jumps 6.4%
finance.yahoo.com - November 6 at 11:25 AM |
| Bronstein, Gewirtz & Grossman, LLC Announces Investigation of FibroGen, Inc. (FGEN)
finance.yahoo.com - November 6 at 11:25 AM |
| Jazz Pharma (JAZZ) Q3 Earnings Beat, Xyrem Drives Sales
finance.yahoo.com - November 6 at 11:25 AM |
| SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of FibroGen, Inc. - FGEN - GlobeNewswire
www.globenewswire.com - November 5 at 10:26 PM |
 | HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages FibroGen (FGEN) Investors to Contact Its Attorneys Now, Firm Investigating Possible Securities Fraud - PRNewswire
www.prnewswire.com - November 5 at 10:26 PM |
